🎧 New: AI-Generated Podcasts Turn your study notes into engaging audio conversations. Learn more

Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Document Details

HeartfeltZombie6369

Uploaded by HeartfeltZombie6369

Northwestern University of the Philippines

Tags

pharmacology drugs medicine healthcare

Summary

This document is a pharmacology review covering various aspects of the subject. It discusses drug classifications, mechanisms of action, and relevant laws. The document includes detailed information about different types of drugs, their uses, and their effects.

Full Transcript

**PHARMACOLOGY** - The study of chemical drugs on living tissue and how those chemicals help diagnose and prevent disease - Study of the mechanisms of action of drugs - What drugs does to the body - Study drug actions as they move through the body - What the body does to drugs 1....

**PHARMACOLOGY** - The study of chemical drugs on living tissue and how those chemicals help diagnose and prevent disease - Study of the mechanisms of action of drugs - What drugs does to the body - Study drug actions as they move through the body - What the body does to drugs 1. **PROPHYLACTIC/PREVENTIVE-** Prevent a disease from occurring 2. **DIAGNOSTIC-** Detects the nature of diseases 3. **THERAPEUTIC** a. **CURATIVE**- treats disease b. **PALLATIVE**- does not affect the disease itself c. **SUPPORTIVE**- sustains patient d. **SUBSTITUTIVE**- take as replacement e. **RESTORATIVE**- help the drug return to its normal healing 4. **PRESCRIPTION DRUGS-** Ordered by the physician 5. **NON-PRESCRIPTION DRUGS/ OVER THE COUNTER DRUGS** - Can be purchased from a pharmacy without prescription 6. **INVESTIGATIONAL DRUGS-** Drugs under study, not yet approved 7. **ILLICIT DRUGS/ ILLEGAL DRUGS-** Drugs that are abused 1. **OFFICIAL NAME-** Listed on official publication as a drug reference 2. **CHEMICAL NAME** - Describes the drugs chemical structure on - Complex for general use 3. **GENERIC NAME-** Not owned by any drug company 4. **PROPRIETY NAME/ BRAND NAME-** Usually a trademark owned by the specific manufacturer - It validates the need for research on how drugs work - It undergoes 3.5 years of laboratory a. **PRE**-**CLINICAL** **TRIALS**- drug tested on animals b. **PHASE** **1**- uses 20-80 volunteers takes about 1 year c. **PHASE** **II**- 100-300 and takes about 2 years d. **PHASE** **III**- 1000-3000 in clinics and hospitals and takes about 3 years - Applies for FDA approval and takes about 2.5 years **PREGNANCY CATEGORIES** **PRE**-**CATEGORIES**- 1979 to indicate the potential risk birth defects of drugs a. **CATEGORY** **A**- adequate and well controlled, no evidence of risk and safe during pregnancy b. **CATEGORY** **B-** Animal used in study, no adverse effect in animals but no study in human c. **CATEGORY** **C**- has an adverse effect on animals and well controlled studies in humans d. **CATEGORY** **D**- adverse effect in humans and the benefit outweighs the risk e. **CATEGORY** **X**- the risk in pregnancy outweighs the benefits and causes abortion **PREGNANCY AND LACTATION LABELLING FINAL RULE (PLLR)** - June 30, 2015 and removed by June 29, 2018 **RELEVANT DRUG LAWS** 1. **GENERIC ACT OF 1988 (RA 6675)** - Ensure production of an adequate supply 2. **ADMINISTRATIVE ORDER NO. 62 S. 1989** - Rules and regulations to implement prescribing requirements - Use of generic names in all prescriptions **PARTS OF THE MEDICAL PRESCRITION** a. **SUPRERSCRITION**- Consists of the heading where the symbol Rx b. **INSCRIPTION**- body of prescription c. **SUBSCRIPTION**- special description for the pharmacists d. **SIGNATURE****SINGLE** **ORDER**- given once c. **PRN** **ORDER**- necessary d. **STAT ORDER-** immediately 3. **RIGHT** **DOSE****stable**- occurs with predictable stress **Unstable****Prinzmetal** **ANTIARRHYTHMIC** **DRUGS** \- restore the cardiac rhythm to normal.\ **CARDIAC** **DYSRHYTHMIA****NIACIN** (**VITAMIN** **B3**)- very effective at lowering cholesterol levels\ 6. **ANTICOAGULANTS**- used to inhibit clot formation.\ â—‹ **venous** **problems** - DVT (deep vein thrombosis â—‹ **arterial** **problems** - coronary thrombosis or MI **CLASSIFICATIONS**\ 1. **HEPARIN** (heparin sodium)- Introduced in 1938,is a natural substance in the liver that prevents clot\ - First used in blood transfusions to prevent clotting and used in open heart surgery to prevent blood from clotting 2.**LOW**- **MOLECULAR** - **WEIGHT** **HEPARINS**- introduced to prevent venous thromboembolism.\ - Inactivates the Xa factor, but it is less able to inactivate thrombin. Ex. Enoxaparin sodium Dalteparin sodium\ - **FONDAPARINUX**- designed to be effective as a once-daily SQ injection.\ 3. **DIRECT** **THROMBIN** **INHIBITORS**- directly inhibit thrombin from converting fibrinogen to fibrin.\ - More expensive than the other aanticoagulants.\ Ex. Argatroban Bivalirudin Lepirudin\ Desirudin Dabigatran\ 4. **ORAL** **ANTICOAGULANTS**\ a. **WARFARIN**- oral anticoagulant from the coumarin drug family.\ - Inhibits hepatic synthesis of Vitamin K, thus affecting the clotting actors II, VII, IX and X. b\. **FACTOR** **Xa** **INHIBITORS**- Block activity of clotting factor Xa to prevent clot formation.\ - It activates prothrombin to thrombin Ex. Rivaroxaban Apixaban Edoxaban **THROMBOLYTICS****HISTAMINE** **ANTAGONISTS**\ - They compete with histamine for receptor sites, preventing a histamine response.\ - Decrease nasopharyngeal secretions by blocking the H1 (histamine 1)receptor.\ a. **FIRST-GENERATION** **ANTIHISTAMINES**.\ - They have anticholinergic properties that can cause dryness of\ the mouth and decrease secretions.\ Ex. Brompheniramine maleate Chlorpheniramine maleate Clemastine fumarate Diphenhydramine Cyproheptadine HCl Levocitirizine (Xyzal)\ Chlorcyclizine b\. **SECOND**-**GENERATION** **ANTIHISTAMINES**- Frequently called nonsedating antihistamines- they have little to no effect on sedation.\ Ex. Azelastine Cetirizine Fexofenadine Loratadine Desloratadine 2. **NASAL & SYSTEMIC DECONGESTANTS**\ a. **NASAL** **DECONGESTANT**- stimulate the alpha- adrenergic receptors, thus producing vascular constriction of the capillaries within the nasal mucosa.\ b. **SYSTEMIC** **DECONGESTANT** (alpha adrenergic agonists)- Primarily used for allergic rhinitis\ - They relieve nasal congestion for a longer period than nasal decongestants.\ Ex. Ephedrine Phenylephrine Phenylpropanolamine\ Pseudoephedrine Oxymetazoline Naphazoline\ Tetrahydrozoline 3. **INTRANASAL GLUCOCORTICOIDS**\ - Are effective for treating allergic rhinitis/hay fever Ex. Beclomethasone Budesonide Flunisolide\ Fluticasone Triamcinolone\ 4. **ANTITUSSIVES**- Act on the cough control center in the medulla to suppress the cough reflex.\ - Given if the cough is non productive and irritating.\ **TYPES**:\ a. **NARCOTIC** **ANTITUSSIVES**\ Ex. Codeine Dextromethorpan\ Homatropine and Hydrocodone Guaifenesin and codeine b\. **NON** **NARCOTIC** **ANTITUSSIVES**- does not depress respiration\ Ex. Benzonatate 5\. **EXPECTORANTS**- Loosen bronchial secretions so they can be eliminated with coughing.\ Ex. Guaifenesin **B. DRUGS FOR ACUTE AND CHRONIC LOWER RESPIRATORY DISORDERS**\ 1. **BRONCHODILATORS**\ a. **SYMPATHOMIMETICS**- Increase cAMP, causing dilation of the bronchioles.\ - **cAMP**- cyclic adenosine monophosphate- activates target enzymes in the\ cells\ Ex. Albuterol- newer beta adrenergic drug Metaproterenol- first marketed in 1961\ Isoproterenol- introduced in 1941 Levalbuterol\ Salmeterol Terbutaline Sulfate\ Arformoterol Indacaterol\ Olodaterol b\. **METHYLXANTINE**- Used in the treatment of asthma.\ Ex. Aminophylline-theophylline- for maintenance Doxophylline c\. **ANTICHOLINERGICS**- Dilates the bronchi and decreases bronchial secretions.\ Ex. Ipratropium bromide- used to treat asthmatic conditions by dilating the bronchioles Glycopyrrolate Aclidinium\ Tiotropium- used for maintenance treatment of bronchospasms 2\. **LEUKOTRIENE** **MODIFIERS**\ - Are effective in reducing the inflammatory symptoms of asthma triggered by allergic and environmental stimuli thus decreasing bronchoconstriction.\ - not recommended for treatment of acute asthmatic attacks **LEUKOTRIENE** (LT)- a chemical mediator that can cause inflammatory changes in the lungs.\ **Cysteinyl** leukotrienes- promote an increase in eosinophil migration, mucous production, and airway wall edema that results in bronchoconstriction.\ Ex. Zafirlukast- first drug in this class. Zileuton Montelukast sodium- new LT receptor\ 3. **GLUCOCORTICOIDS** (STEROIDS)\ - Used to treat respiratory disorders, particularly asthma.\ 4. **MAST CELL STABILIZER**\ - **CROMOLYN SODIUM**- Used for prophylactic treatment of bronchial asthma and not used for\ acute asthmatic attacks.\ 5. **MUCOLYTICS**- Act like detergents to liquefy and loosen thick mucous secretions so they\ can be expectorated.\ Ex. Acetylcisteine\ o Antidote also for Acetaminophen overdose\ Acetylcisteine Carbocisteine Ambroxol

Use Quizgecko on...
Browser
Browser